Tag: AFNET
Controlling heart rhythm reduces adverse outcomes in atrial fibrillation
Around 2% of the European population suffer from atrial fibrillation, a heart condition characterised by a change in heart rhythm that increases the risk of serious health complications. Currently, therapies to directly address the arrhythmia are not used for all patients. The Atrial Fibrillation Network Association (AFNET) was the responsible organisation for the EAST-AFNET 4 trial, which set out to […]
Read More… from Controlling heart rhythm reduces adverse outcomes in atrial fibrillation